1. Home
  2. RAPT vs MPA Comparison

RAPT vs MPA Comparison

Compare RAPT & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • MPA
  • Stock Information
  • Founded
  • RAPT 2015
  • MPA 1992
  • Country
  • RAPT United States
  • MPA United States
  • Employees
  • RAPT N/A
  • MPA N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • MPA Finance Companies
  • Sector
  • RAPT Health Care
  • MPA Finance
  • Exchange
  • RAPT Nasdaq
  • MPA Nasdaq
  • Market Cap
  • RAPT 117.5M
  • MPA 139.0M
  • IPO Year
  • RAPT 2019
  • MPA N/A
  • Fundamental
  • Price
  • RAPT $7.35
  • MPA $10.78
  • Analyst Decision
  • RAPT Buy
  • MPA
  • Analyst Count
  • RAPT 5
  • MPA 0
  • Target Price
  • RAPT $42.00
  • MPA N/A
  • AVG Volume (30 Days)
  • RAPT 120.8K
  • MPA 25.2K
  • Earning Date
  • RAPT 08-07-2025
  • MPA 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • MPA 3.83%
  • EPS Growth
  • RAPT N/A
  • MPA N/A
  • EPS
  • RAPT N/A
  • MPA N/A
  • Revenue
  • RAPT N/A
  • MPA N/A
  • Revenue This Year
  • RAPT N/A
  • MPA N/A
  • Revenue Next Year
  • RAPT N/A
  • MPA N/A
  • P/E Ratio
  • RAPT N/A
  • MPA N/A
  • Revenue Growth
  • RAPT N/A
  • MPA N/A
  • 52 Week Low
  • RAPT $5.67
  • MPA $9.87
  • 52 Week High
  • RAPT $30.60
  • MPA $12.21
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 43.57
  • MPA 47.36
  • Support Level
  • RAPT $6.88
  • MPA $10.65
  • Resistance Level
  • RAPT $8.91
  • MPA $10.80
  • Average True Range (ATR)
  • RAPT 0.70
  • MPA 0.09
  • MACD
  • RAPT -0.16
  • MPA 0.00
  • Stochastic Oscillator
  • RAPT 11.36
  • MPA 48.15

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About MPA Blackrock MuniYield Pennsylvania Quality Fund

Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.

Share on Social Networks: